The Latest Breaking News from Psoriasis

Kim Kardashian's psoriasis battle as fans spot red leg mark in unfiltered bikini pics

Kim Kardashian has been spotted struggling with a flare-up of psoriasis. She's been open about her battle with the painful autoimmune disease throughout her career

Daily Mirror · Jul 13, 2022

Nurse had sore throat and ended up with 'leopard print' skin

A nurse has claimed that a sore throat left her with 'leopard print' skin condition

Wales Online · Jul 5, 2022

Best products to help treat psoriasis: Top creams, balms and lotions

Help soothe and heal with these carefully formulated body and skincare buys

Evening Standard · Jul 4, 2022

Can-Fite BioPharma Shares Jump After Piclidenoson Data In Psoriasis Trial

Can-Fite BioPharma Ltd (NYSE:CANF) announced topline results from the COMFORT Phase 3 trial of Piclidenoson in more than 400 adults with moderate to severe plaque psoriasis. The study data show that patients treated with oral Piclidenoson 2 mg or 3 mg twice daily had clinically equivalent efficacy responses.  At week 16, patients receiving…

Benzinga · Jun 29, 2022

Soligenix Gets FDA Nod For Mid-Stage Psoriasis Study

The U.S. Food and Drug Administration (FDA) has cleared Soligenix’s (NASDAQ: SNGX) Investigational New Drug (IND) application for Phase 2a clinical trial Evaluating SGX302 in the treatment of patients with Mild-to-Moderate Psoriasis.

Benzinga · Jun 28, 2022

Mum given devastating choice between life-changing medication and having a baby

Rebecca Sayers suffers from the lifelong chronic skin condition psoriasis

Chronicle Live · Jun 24, 2022

Student blames horrific 'red raw' sores covering 90% of body on sharing vapes with pals

Emily Angel Pellegrini, 21, visited the doctor after she first noticed a tiny scab under her boob at the start of the year but just dismissed it as friction from her bra

Daily Mirror · Jun 20, 2022

Letter: Lady Knight of Collingtree obituary

Ray Jobling writes: Jill Knight made a great contribution to the Psoriasis Association

The Guardian - UK · Jun 8, 2022

Can-Fite Q1 Revenue Increases 38.5%, Phase III Psoriasis Treatment Study Results Expected In Q2

Can-Fite BioPharma Ltd. (AMEX:CANF) (TASE: CFBI) released financial results for the quarter ended March 31, 2022, revealing revenue of $200,000, an increase of or 38.5%, compared to $150,000 in Q1 2021. Q1 Financial Highlights

Benzinga · May 26, 2022

This Mid-Cap Firm Can Potentially Offer Biggest Oral Drug In Atopic Dermatitis, Cantor Thinks So

Cantor assumes coverage of RAPT Therapeutics Inc (NASDAQ:RAPT) with an Overweight rating and a price target of $44 (vs. $58 previously).  The analyst says the company's RPT193 (lead inflammation drug) could be a $3 billion drug in just atopic dermatitis (AD) indication, as it expects AD to outperform psoriasis. Cantor suggests that ‘193 is…

Benzinga · May 25, 2022